Waning intestinal immunity after vaccination with oral poliovirus vaccines in India
- PMID: 22448007
- DOI: 10.1093/infdis/jis241
Waning intestinal immunity after vaccination with oral poliovirus vaccines in India
Abstract
Background: The eradication of wild-type polioviruses in areas with efficient fecal-oral transmission relies on intestinal mucosal immunity induced by oral poliovirus vaccine (OPV). Mucosal immunity is thought to wane over time but the rate of loss of protection has not been examined.
Methods: We examined the degree and duration of intestinal mucosal immunity in India by measuring the prevalence of vaccine poliovirus in stool samples collected 4-28 days after a "challenge" dose of OPV among 47 574 children with acute flaccid paralysis reported during 2005-2009.
Results: Previous vaccination with OPV was protective against excretion of vaccine poliovirus after challenge, but the odds of excretion increased significantly with the time since the child was last exposed to an immunization activity (odds ratio, 1.39 [95% confidence interval .99-1.97], 2.04 [1.28-3.25], and 1.31 [1.00-1.70] comparing ≥6 months with 1 month ago for serotypes 1, 2, and 3, respectively). Vaccine administered during the high season for enterovirus infections (April-September) was significantly less likely to result in excretion, especially in northern states (odds ratio, 0.57 [95% confidence interval, .50-.65], 0.58 [.41-.81], and 0.48 [.40-.57] for serotypes 1, 2, and 3).
Conclusions: Infection with OPV (vaccine "take") is highly seasonal in India and results in intestinal mucosal immunity that appears to wane significantly within a year of vaccination.
Similar articles
-
Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India.J Infect Dis. 2009 Sep 1;200(5):794-801. doi: 10.1086/605330. J Infect Dis. 2009. PMID: 19624278
-
Anomalous observations on IPV and OPV vaccination.Dev Biol (Basel). 2001;105:197-208. Dev Biol (Basel). 2001. PMID: 11763328
-
Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccination.J Infect Dis. 2010 May 15;201(10):1535-43. doi: 10.1086/651952. J Infect Dis. 2010. PMID: 20367459
-
Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge.PLoS Pathog. 2012;8(4):e1002599. doi: 10.1371/journal.ppat.1002599. Epub 2012 Apr 19. PLoS Pathog. 2012. PMID: 22532797 Free PMC article. Review.
-
Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus.Acta Virol. 2000 Apr;44(2):109-17. Acta Virol. 2000. PMID: 10989702 Review.
Cited by
-
Review of Poliovirus Transmission and Economic Modeling to Support Global Polio Eradication: 2020-2024.Pathogens. 2024 May 22;13(6):435. doi: 10.3390/pathogens13060435. Pathogens. 2024. PMID: 38921733 Free PMC article. Review.
-
Population Immunity and Polio Eradication.Pathogens. 2024 Feb 20;13(3):183. doi: 10.3390/pathogens13030183. Pathogens. 2024. PMID: 38535527 Free PMC article. Review.
-
Does IPV Boost Intestinal Immunity among Children under Five Years of Age? An Experience from Pakistan.Vaccines (Basel). 2023 Sep 1;11(9):1444. doi: 10.3390/vaccines11091444. Vaccines (Basel). 2023. PMID: 37766121 Free PMC article.
-
Inactivated Poliovirus Vaccine Closing the Type 2 Immunity Gap in Vietnam.J Pediatric Infect Dis Soc. 2022 Sep 29;11(9):413-416. doi: 10.1093/jpids/piac046. J Pediatric Infect Dis Soc. 2022. PMID: 35801634 Free PMC article.
-
Poliovirus immunity among adults in the Democratic Republic of the Congo: a cross-sectional serosurvey.BMC Infect Dis. 2022 Jan 5;22(1):30. doi: 10.1186/s12879-021-06951-6. BMC Infect Dis. 2022. PMID: 34986786 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous